[Edaily Reporter Kim Jinsoo ] Value Added Technology Co., Ltd.(043150)is accelerating its global growth through a “dual-track strategy”: raising average selling prices with premium products in developed markets while increasing sales volume in Shinhung markets by leveraging mid-range and entry-level products and local subsidiaries.
In particular, the company aims to expand its market presence in Europe with the “Green X 21,” a large-scale dental computed tomography (CT) scanner that has already been validated in the U.S., and in Asia and Latin America through price-competitive products.
(Photo: AI-generated)
According to Value Added Technology Co., Ltd. on the 10th, consolidated revenue for the second quarter of this year reached 121.362 billion won, a 9.7% increase compared to the same period last year. During the same period, operating profit rose 45.0% to 24.473 billion won, and the operating profit margin increased by 4.9 percentage points from 15.3% to 20.2%. Revenue reached a record high for a single quarter, marking the sixth consecutive quarter of year-over-year growth.
Cumulative revenue for the first half of the year was 226.56 billion won, and operating profit was 35.468 billion won, representing increases of 6.9% and 17.9%, respectively. The operating profit margin for the first half also rose by 1.5 percentage points year-over-year to 15.7%.
Financial information provider FnGuide forecasts that Value Added Technology Co., Ltd. will post revenue of 455.3 billion won and operating profit of 61.5 billion won this year. These figures represent increases of 7% and 11%, respectively, compared to last year. If growth on the global stage continues as expected, the six consecutive quarters of revenue growth and improved profitability are likely to continue into the second half of the year.
Value Added Technology Co., Ltd. is an export-oriented company that generates more than 90% of its revenue overseas. Exports in the first half of this year totaled 210.9 billion won, accounting for 93.1% of total revenue. By region, Europe accounted for 31.3% of revenue and North America 29.1%; combined, these two markets make up over 60% of the total. In effect, growth in the U.S. and Europe is driving Value Added Technology Co., Ltd.’s overall performance.
Value Added Technology Co., Ltd. is raising its average selling price (ASP) by selling premium equipment with high performance and a wide imaging range in developed markets, while simultaneously increasing unit sales—primarily of mid-range and entry-level models—in Shinhung markets such as Asia, Latin America, and the Commonwealth of Independent States (CIS). The company is targeting these markets with a dual-track strategy tailored to regional characteristics.
‘GreenX21,’ Proven in the U.S., Begins Full-Scale Sales in Europe
At the heart of the company’s strategy for developed markets is the premium CT system, the GreenX21. After obtaining approval from the U.S. Food and Drug Administration (FDA) in February of last year, Value Added Technology Co., Ltd. launched the GreenX21
in the U.S.
in April of the same year—the first time the system was sold anywhere in the world. By selecting the U.S. market—where demand for CT is high—as the first launch region, the company was able to confirm the market potential of this premium product early on.
The GreenX21 offers a large field of view (FOV) of up to 21 × 19 cm, allowing the entire craniofacial region—from the chin to the forehead—to be imaged in a single scan. Using ultra-fine voxels measuring 0.05 mm, it can visualize nerves and roots inside the teeth and is applicable not only to oral surgery, orthodontics, dentofacial orthopedics, and endodontics but also to otolaryngology diagnostics. Another key differentiator is its ability to capture CT, panoramic, and cephalometric images in a single scan and perform a 3D facial scan to compare pre- and post-orthodontic treatment results.
Since the GreenX21 has a higher selling price compared to the company’s existing mid-range flagship products, an increase in unit sales will contribute not only to revenue growth but also to improved profitability. In the second quarter of this year, standalone revenue from 3D dental CT systems reached 42.125 billion won, a 6.8% increase year-over-year. 3D equipment accounted for 58.3% of total product sales.
Value Added Technology Co., Ltd. is expanding the sales experience it has gained in the U.S. to Europe. The company is expected to accelerate its market entry after completing CE MDR certification—the European medical device regulation—for its entire line of diagnostic imaging devices, including dental CT scanners, digital panoramic X-ray units, and intraoral X-ray units, in June of this year.
Value Added Technology Co., Ltd. is experiencing rapid growth in Europe. The company’s second-quarter sales in Europe totaled 37.505 billion won, a 23.4% increase year-over-year, accounting for 30.9% of total revenue. By country, sales in France rose 44.2%, in the Czech Republic 38.9%, and in Germany 27.1%. Value Added Technology Co., Ltd. currently operates local subsidiaries in major European countries such as France, the United Kingdom, the Czech Republic, and Spain, and is actively pursuing sales through these entities.
In the medium to long term, demand for the replacement of existing equipment is also expected. Dental imaging equipment is typically replaced with new models after about 7 to 10 years of use, and replacement demand for units sold in 2021–2022—a period when investment in dental equipment expanded following the COVID-19 pandemic—is projected to begin in 2028.
Shinhung Markets: Expanding Sales Through
Entry-Level Models
and Local Subsidiaries
In Shinhung markets, revenue growth is expected to be driven by mid-range and entry-level products that offer price competitiveness. Unlike SUNJIN Co., Ltd., Shinhung markets are highly price-sensitive and have a higher proportion of general dental care, resulting in relatively high demand for 2D panoramic equipment and mid-to-low-priced 3D CT scanners.
Value Added Technology Co., Ltd. is targeting these markets with products such as the cost-competitive entry-level “A9” and the mid-to-low-priced “Smart X.” In fact, sales of 2D X-ray products in the second quarter of this year reached 10.678 billion won, a 14.3% increase year-over-year, recording a higher growth rate than 3D products.
The company is also aggressively expanding its local subsidiaries. Value Added Technology Co., Ltd. has sales subsidiaries in Brazil, Mexico, India, Vietnam, Kazakhstan, and the United Arab Emirates (UAE), and has recently expanded its presence to Armenia, Türkiye, Kyrgyzstan, Colombia, and Poland. The company’s strategy is to use these local subsidiaries to directly address changes in demand, regulatory approvals, and customs clearance, while also providing post-sale services such as installation, training, and after-sales support.
A Value Added Technology Co., Ltd. official stated, “We have maintained our growth momentum in key markets such as Europe and Asia, driven by our product competitiveness and local business capabilities,” adding, “We will continue to expand our global market presence through differentiated solutions.”
The shadow of another capital increase is looming over the artificial intelligence (AI) diagnostics company Noul Co., Ltd.(376930). Having raised approximately 25 billion won through a capital increas…
On the 10th, shares of DRTECH Corporation(214680), which resumed trading after completing a stock consolidation, experienced significant volatility in the pharmaceutical and biotech sector. DRTECH Cor…
Artificial intelligence (AI) translation and interpretation technology, which was previously used mainly in tourism and international conferences, is now making inroads into manufacturing and safety s…